Ikarian Capital, LLC Q1 2020 Filing
Filed May 15, 2020
Portfolio Value
$1.3M
Holdings
115
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (115 positions)
| Stock | Value |
|---|---|
SPYSPDR S&P 500 ETF TR | $309.3M |
XLRNACCELERON PHARMA INC | $68.9M |
TLTISHARES TR | $66.0M |
REGNREGENERON PHARMACEUTICALS | $63.5M |
—SUNESIS PHARMACEUTICALS INC | $46.0M |
BIIBBIOGEN INC | $45.6M |
ALNYALNYLAM PHARMACEUTICALS INC | $40.0M |
XBISPDR SER TR | $38.7M |
—ZOGENIX INC | $37.4M |
ARGXARGENX SE | $35.1M |
AXSMAXSOME THERAPEUTICS INC | $30.9M |
NDQINVESCO QQQ TR | $29.6M |
—MYOKARDIA INC | $25.0M |
IWMISHARES TR | $18.9M |
GILDGILEAD SCIENCES INC | $18.7M |
RETAEURREATA PHARMACEUTICALS INC | $18.0M |
ALXNALEXION PHARMACEUTICALS INC | $18.0M |
BTAIEURBIOXCEL THERAPEUTICS INC | $17.8M |
ACADACADIA PHARMACEUTICALS INC | $16.5M |
LGNDLIGAND PHARMACEUTICALS INC | $14.5M |
ICPTUSDINTERCEPT PHARMACEUTICALS IN | $14.0M |
VSTMVERASTEM INC | $13.9M |
IMVTIMMUNOVANT INC | $13.1M |
BHVNBIOHAVEN PHARMACTL HLDG CO L | $11.9M |
MRTXEURMIRATI THERAPEUTICS INC | $11.4M |
ABBVABBVIE INC | $11.4M |
KPTIEURKARYOPHARM THERAPEUTICS INC | $11.3M |
CYTKCYTOKINETICS INC | $10.4M |
—ARTARA THERAPEUTICS INC | $10.4M |
ADVMCHFADVERUM BIOTECHNOLOGIES INC | $10.2M |
SRPTSAREPTA THERAPEUTICS INC | $10.0M |
—ADURO BIOTECH INC | $10.0M |
FGENEURFIBROGEN INC | $9.7M |
SG7SAGE THERAPEUTICS INC | $9.7M |
NBIXNEUROCRINE BIOSCIENCES INC | $8.7M |
ARDXARDELYX INC | $8.3M |
SCPHSCPHARMACEUTICALS INC | $7.9M |
OCULOCULAR THERAPEUTIX INC | $7.7M |
CRSPCRISPR THERAPEUTICS AG | $7.6M |
IM8NINSMED INC | $7.6M |
—CHIASMA INC | $7.6M |
KURAKURA ONCOLOGY INC | $7.6M |
CARAEURCARA THERAPEUTICS INC | $7.6M |
CLVSEURCLOVIS ONCOLOGY INC | $7.5M |
—MILLENDO THERAPEUTICS INC | $7.4M |
KALVKALVISTA PHARMACEUTICALS INC | $7.2M |
GLPGGALAPAGOS NV | $6.9M |
2L9BLUEPRINT MEDICINES CORP | $6.8M |
AVDLAVADEL PHARMACEUTICALS PLC | $6.6M |
—STRONGBRIDGE BIOPHARMA PLC | $6.4M |
CCXIEURCHEMOCENTRYX INC | $6.0M |
CVM1EURCEL SCI CORP | $5.8M |
KNSAKINIKSA PHARMACEUTICALS LTD | $5.6M |
—KADMON HLDGS INC | $5.5M |
RAREULTRAGENYX PHARMACEUTICAL IN | $5.1M |
XENEXENON PHARMACEUTICALS INC | $5.0M |
AUPHAURINIA PHARMACEUTICALS INC | $4.6M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $4.6M |
ASMBASSEMBLY BIOSCIENCES INC | $4.6M |
NERVGBPMINERVA NEUROSCIENCES INC | $4.4M |
KALAKALA PHARMACEUTICALS INC | $4.3M |
1T7TRICIDA INC | $4.0M |
ITCIEURINTRA CELLULAR THERAPIES INC | $3.8M |
ASNDASCENDIS PHARMA A S | $3.8M |
BMY-RBRISTOL-MYERS SQUIBB CO | $3.6M |
BLUEBLUEBIRD BIO INC | $3.5M |
CBAYUSDCYMABAY THERAPEUTICS INC | $3.5M |
MYOVMYOVANT SCIENCES LTD | $3.4M |
OTICEUROTONOMY INC | $3.3M |
MDGLMADRIGAL PHARMACEUTICALS INC | $2.7M |
ALLKGUSDALLAKOS INC | $2.7M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $2.6M |
BBIOBRIDGEBIO PHARMA INC | $2.5M |
SLDBSOLID BIOSCIENCES INC | $2.4M |
NTLAINTELLIA THERAPEUTICS INC | $2.3M |
ARVNARVINAS INC | $2.3M |
FATEFATE THERAPEUTICS INC | $2.2M |
—CASI PHARMACEUTICALS INC | $2.1M |
MGNXMACROGENICS INC | $2.1M |
RLMDRELMADA THERAPEUTICS INC | $1.9M |
INOINOVIO PHARMACEUTICALS INC | $1.9M |
ADMAADMA BIOLOGICS INC | $1.8M |
—APPLIED GENETIC TECHNOL CORP | $1.8M |
BDQMALBIREO PHARMA INC | $1.6M |
—IMMUNOMEDICS INC | $1.6M |
NXTCNEXTCURE INC | $1.5M |
—CERECOR INC | $1.4M |
APLSAPELLIS PHARMACEUTICALS INC | $1.4M |
CHRSCOHERUS BIOSCIENCES INC | $1.4M |
—APTINYX INC | $1.3M |
SAVACASSAVA SCIENCES INC | $1.2M |
QNCXCORTEXYME INC | $1.1M |
OVIDOVID THERAPEUTICS INC | $1.1M |
PTGXPROTAGONIST THERAPEUTICS INC | $1.1M |
—DBV TECHNOLOGIES S A | $1.1M |
IFRXINFLARX NV | $1.0M |
MBIOUSDMUSTANG BIO INC | $955K |
BLUBELLUS HEALTH INC NEW | $891K |
ICADUSDICAD INC | $786K |
VKTXVIKING THERAPEUTICS INC | $590K |
Page 1 of 2Next